Safety and Efficacy of Vedolizumab in a Patient With Crohn's Disease After Developing An Active Tuberculosis Infection Associated With Infliximab-Biosimilar: A Case Report
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI